4//SEC Filing
TITAN PHARMACEUTICALS INC 4
Accession 0001144204-14-060879
$TTNPCIK 0000910267operating
Filed
Oct 13, 8:00 PM ET
Accepted
Oct 14, 12:09 PM ET
Size
9.3 KB
Accession
0001144204-14-060879
Insider Transaction Report
Form 4
TITAN PHARMACEUTICALS INCTTNP.OB
BHONSLE SUNIL
DirectorPresident
Transactions
- Purchase
Common Stock
2014-10-10$0.49/sh+24,000$11,688→ 0 total - Purchase
Common Stock
2014-10-09$0.48/sh+100,000$47,800→ 0 total - Purchase
Common Stock
2014-10-13$0.47/sh+92,000$43,240→ 356,500 total
Holdings
- 300,757(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Represents the weighted average purchase price for the reported transactions. The range of prices for such transactions was $0.468 to $0.49. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F2]Represents the weighted average purchase price for the reported transactions. The range of prices for such transactions was $0.463 to $0.485. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F3]Does not include 10,000 shares held by his adult son.
- [F4]The reporting person is the trustee of the family trust owning the indicated shares.
Documents
Issuer
TITAN PHARMACEUTICALS INC
CIK 0000910267
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000910267
Filing Metadata
- Form type
- 4
- Filed
- Oct 13, 8:00 PM ET
- Accepted
- Oct 14, 12:09 PM ET
- Size
- 9.3 KB